2015
DOI: 10.1523/jneurosci.5241-14.2015
|View full text |Cite
|
Sign up to set email alerts
|

PKR Inhibition Rescues Memory Deficit and ATF4 Overexpression in ApoE ε4 Human Replacement Mice

Abstract: Sporadic Alzheimer's disease (AD) is an incurable neurodegenerative disease with clear pathological hallmarks, brain dysfunction, and unknown etiology. Here, we tested the hypothesis that there is a link between genetic risk factors for AD, cellular metabolic stress, and transcription/translation regulation. In addition, we aimed at reversing the memory impairment observed in a mouse model of sporadic AD. We have previously demonstrated that the most prevalent genetic risk factor for AD, the ApoE4 allele, is c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
48
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(52 citation statements)
references
References 54 publications
(3 reference statements)
3
48
0
Order By: Relevance
“…Nevertheless, increasing translation could ameliorate the disease. Indeed, both genetic reduction of eIF2α phosphorylation (PKR or PERK knockout mice and GADD34-overexpressing vectors) or pharmacological correction of the abnormal translational program controlled by eIF2α (e.g., using ISRIB and PKR inhibitors) reverses the cognitive decline associated with AD (Lourenco et al 2013;Ma et al 2013;Segev et al 2015), traumatic brain injury (Chou et al 2017), as well as the pathology associated with prion disease (Moreno et al 2012).…”
Section: Perturbed Translational Control In Neurological Disordersmentioning
confidence: 99%
“…Nevertheless, increasing translation could ameliorate the disease. Indeed, both genetic reduction of eIF2α phosphorylation (PKR or PERK knockout mice and GADD34-overexpressing vectors) or pharmacological correction of the abnormal translational program controlled by eIF2α (e.g., using ISRIB and PKR inhibitors) reverses the cognitive decline associated with AD (Lourenco et al 2013;Ma et al 2013;Segev et al 2015), traumatic brain injury (Chou et al 2017), as well as the pathology associated with prion disease (Moreno et al 2012).…”
Section: Perturbed Translational Control In Neurological Disordersmentioning
confidence: 99%
“…Interestingly, ATF4 seems to be locally translated in axons in response to Aβ peptide stimulation and in addition it is retrogradely transported, which is necessary for Aβ‐mediated cell death [Baleriola et al, ]. Genetic and environmental risk factors for sporadic AD are also associated with increased eIF2α phosphorylation in mouse models [Segev et al, ]. Interestingly, eIF2α phosphorylation increases the translation of BACE1, one of the enzymes responsible for APP cleavage, suggesting a vicious cycle, in which phosphorylated eIF2α promotes Aβ production and vice‐versa [O'Connor et al, ; Mouton‐Liger et al, ; Devi and Ohno, ].…”
Section: Eif2α In Neurodegenerative Diseasesmentioning
confidence: 99%
“…At the same time, dysregulation of these mechanisms underlies various neurodevelopmental and neurodegenerative pathologies. Both the initiation and elongation phases of mRNA translation and the respective translation factors that mediate them have been suggested as innovative targets for memory enhancement in health and disease (56,(59)(60)(61)(62)(63)111).…”
Section: Introductionmentioning
confidence: 99%